Thus, a monoclonal antibody to HERV-W ENV may be significant as a novel therapy for schizophrenia treatment. 4.
← all excerpts
HERV-W ENV Induces Innate Immune Activation and Neuronal Apoptosis via linc01930/cGAS Axis in Recent-Onset Schizophrenia.
1
—
—